1Department of Endocrinology, Christie Hospital NHS Trust, Manchester, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Long-term administration of hexarelin, a growth hormone (GH)-releasing peptide, causes a partial and reversible decrease in GH release. This study in elderly individuals shows the GH response recovers after therapy cessation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: